UNSPSC 51284403: Ceftobiprole medocaril

This classification denotes a cephalosporin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N99027V28J. European Medicines Agency schedules Ceftobiprole medocaril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25721. Ceftobiprole medocaril generally arises in the molecular formula C26H25N8O11S2.NA.

UNSPSC 51284403 Ceftobiprole medocaril is a Commodity code nominally describing a specific fourth-generation cephalosporin antibiotic, but recent state and local solicitations tagged under this code show minimal alignment with that narrow pharmaceutical scope. The recent opportunities block contains four records spanning emergency medical supplies (naloxone and drug deactivation systems), pharmacy benefit management infrastructure (a Texas HHS direct-to-manufacturer prescription initiative), first-aid and respiratory equipment for fire rescue operations, and multi-source generic pharmaceuticals with OTC products through a cooperative purchasing vehicle. Only the Minnesota MMCAP solicitation nominally addresses pharmaceutical procurement at scale, but it solicits manufacturers to supply a broad basket of generic multi-source drugs and OTC items through authorized wholesalers, not ceftobiprole specifically. The disconnect between the code's name and actual procurement activity suggests the code sees little relevant recent volume under its stated commodity scope.

Issuing bodies across the recent records include county health departments (Seminole County, Florida), state health agencies (Texas HHS Commission), municipal fire services (City of Tampa), and multi-state cooperative purchasing consortia (Minnesota MMCAP, serving state and local government facilities across member states including Oregon). Geographic activity is concentrated in the South and Upper Midwest — Florida, Texas, and Minnesota — with the MMCAP vehicle spanning a multi-state footprint. Representative recent solicitations include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline; the City of Tampa's sealed-bid solicitation (26P00145) for 169 line items of medical and first-aid supplies for the Fire Department Rescue Division, estimated at $700,000.00 and designated as a sheltered market opportunity for certified Small Local Business Enterprises, with bids due March 13, 2026; and Minnesota MMCAP's RFP (S1070000015802) for generic multi-source pharmaceuticals and OTC products with proposals due March 26, 2026. The code shows limited actionable activity in its stated pharmaceutical scope.